MRI study of whole-body effects of moderate to severe COVID
Part of Infections clinical trials.
This study looks at how COVID-19 affects multiple organs in the body, using MRI scans and related measurements. It may help researchers better understand who is at risk for longer-lasting or widespread effects after COVID.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can understand the study and sign informed consent
- You are 18 years or older
- You have confirmed COVID-19 from a lab test (RT-PCR)
- Your COVID illness was moderate to severe (for example, pneumonia symptoms or low oxygen levels)
- You must be able to safely have an MRI scan
- Your kidney function must not be severely impaired (eGFR 30 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new MRI scan techniques that aim to capture information from multiple organs in one scan. It may help researchers improve how MRI images are taken and analyzed in fewer visits.
This study uses a heart MRI to look for leftover (healing) changes in heart tissue after COVID-19. It may help researchers better understand what ongoing heart effects can happen after infection.
This study checks how COVID affected people’s health and brain changes using follow-up information and brain scans. It may help researchers understand longer-term effects and what to watch for after COVID, especially in people with mild or moderate illness.
This study enrolls adults who had COVID-19 to track longer-term health effects and match them with people who did not have COVID-19. Depending on eligibility, you may be asked to complete questionnaires and possibly have MRI or X-ray scans.
This study tests a special MRI method that uses lower energy exposure. It aims to improve how well researchers can scan the heart and other organs while keeping the scan as safe and comfortable as possible.
This study uses a special PET scanner to look for inflammation in the brains of people with long-COVID (ongoing symptoms after COVID-19 infection). The scan may help doctors understand what's causing long-COVID and develop better treatments.
Hear when a new Coronavirus Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.